Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (266)
  • Open Access

    REVIEW

    Climate Change and Congenital Heart Disease: A Narrative Review

    Ethan Katznelson1, Matthew J. Navarro2, Su Yuan1, Dhurv S. Kazi3, Harsimran S. Singh1,*

    Congenital Heart Disease, Vol.19, No.6, pp. 627-634, 2024, DOI:10.32604/chd.2025.062309 - 27 January 2025

    Abstract Congenital Heart Disease (CHD) is the most common birth defect and a leading cause of infant morbidity and mortality worldwide. While genetic factors play a significant role in its development, up to 30% of CHD is associated with modifiable risk factors and external maternal exposures. Climate change, driven by increased atmospheric pollutants from fossil fuel combustion, leads to rising global temperatures and worsening air quality, which pose emerging threats to maternal and fetal health. This review explores the mechanisms by which environmental factors associated with climate change, specifically extreme heat and air pollution, may influence… More >

  • Open Access

    REVIEW

    Surgical Ablation in Congenital Heart Disease: Advances in Techniques and Clinical Outcomes

    Manouk H. C. Linderhof1,#, Hoang H. Nguyen1,2,#, Annemien E. van den Bosch1, Mathijs S. van Schie1, Vehpi Yildirim1, Yannick J. H. J. Taverne3, Natasja M. S. de Groot1,*

    Congenital Heart Disease, Vol.19, No.6, pp. 577-592, 2024, DOI:10.32604/chd.2025.062129 - 27 January 2025

    Abstract Surgical ablation (SA) has become an essential rhythm-control strategy for managing tachyarrhythmias in patients with congenital heart disease. Atrial tachyarrhythmias, such as atrial flutter and atrial fibrillation, are prevalent in congenital heart disease, affecting up to 50% of patients, and pose significant risks, including increased morbidity and mortality. Ventricular tachyarrhythmias, though less common, can lead to sudden cardiac death, particularly in conditions like Tetralogy of Fallot. Prior studies suggested that SA for tachyarrhythmias in patients with congenital heart disease offers significant benefits, including superior long-term rhythm control compared to catheter ablation (CA). Atrial tachyarrhythmia burden… More > Graphic Abstract

    Surgical Ablation in Congenital Heart Disease: Advances in Techniques and Clinical Outcomes

  • Open Access

    ARTICLE

    The Factors for Postoperative Peritoneal Dialysis Treatment in Infants after Congenital Cardiac Procedure

    Xiaofeng Wang#, Chenyu Li#, Xia Li, Zhongyuan Lu, Xu Wang*

    Congenital Heart Disease, Vol.19, No.6, pp. 617-626, 2024, DOI:10.32604/chd.2025.058712 - 27 January 2025

    Abstract Objectives: Fluid overload is common after congenital cardiac surgeries. This requires early application of peritoneal dialysis (PD) in infants to improve surgical outcomes. The objective of this study is to ascertain the factors correlated with the necessity for PD in infants, thereby informing the prophylactic placement of PD catheters intraoperatively. Methods: This was a single-center retrospective study. Infants aged three months or younger who underwent congenital cardiac procedures at the Fuwai Hospital between 2021 and 2022 were included. Patients with chronic renal failure or without RACHS-1 categories were excluded. Based on whether postoperative PD treatment… More >

  • Open Access

    CASE REPORT

    Case Report: Prominent Coronary Artery Flow in Fetuses with Congenital Heart Disease, Is It a Marker of In Utero Distress?

    Mohamed Aashiq Abdul Ghayum1,*, Maria Kiaffas1,2, Ashley Warta1, Melanie Kathol1, David C. Mundy2, Kelsey Brattrud1, Nitin Madan1,2

    Congenital Heart Disease, Vol.19, No.6, pp. 647-651, 2024, DOI:10.32604/chd.2025.058271 - 27 January 2025

    Abstract Prominent coronary artery (CA) flow observed on a fetal echocardiogram has been associated with fetal growth restriction and myocardial dysfunction. We present two cases with this finding, in the presence of congenital heart disease (CHD) and absence of growth restriction or myocardial dysfunction. Both the cases rapidly progressed to extremis, necessitating emergent delivery. Our cases highlight the importance of recognizing prominent CA flow in fetuses with CHD as a potential marker for in utero distress. More >

  • Open Access

    REVIEW

    Transcatheter Pulmonary Valve Implantation: A State of the Art Review

    Biagio Castaldi1,*, Francesco Prati1, Alice Pozza1,2, Irene Cattapan1,2, Jennifer Fumanelli1,2, Domenico Sirico1, Giovanni Di Salvo1

    Congenital Heart Disease, Vol.19, No.5, pp. 513-533, 2024, DOI:10.32604/chd.2025.058053 - 31 December 2024

    Abstract Congenital heart disease (CHD) affects about 1% of live births. Among them, about 20% will undergo one or more surgical or percutaneous maneuvers on the right ventricle outflow tract or pulmonary valve. Transcatheter pulmonary valve implantation is a recently available less invasive alternative to surgery for treatment of right ventricular outflow tract dysfunction. Thus, residual dysfunction can be treated early and with a lower risk profile. This narrative review aimed to describe the state of the art of percutaneous pulmonary valve implantation. More >

  • Open Access

    REVIEW

    Unmet Needs in Pediatric and Congenital Heart Surgery: A Review

    Dominique Vervoort1,2,*, Mimi X. Deng2,3, Aliya Izumi4, Shelby Kutty5, Frank Edwin6,7

    Congenital Heart Disease, Vol.19, No.5, pp. 499-511, 2024, DOI:10.32604/chd.2024.057749 - 31 December 2024

    Abstract Pediatric and congenital heart disease (PCHD) affects millions of children worldwide, including over one million babies born with congenital heart disease (CHD) each year and 300,000 children dying from rheumatic heart disease (RHD) yearly. Although the vast majority of children born with CHD in high-income countries now reach adulthood and RHD is nearly eradicated in these countries, most of the world cannot access the necessary care to prevent or mitigate PCHD. In low- and middle-income countries, over 90% of children with PCHD cannot receive the care they need, as over 100 countries and territories… More >

  • Open Access

    ARTICLE

    Evaluation of Post-Operative Atrial Fibrillation after Cardiac Surgery for Adult Congenital Heart Disease

    Jonathan S. Taylor-Fishwick1,*, Nicholas Holzemer2, Brandon Middlemist3, Vivian Duarte3, Kaitlin E. Olson4, Johannes C. von Alvensleben5, Megan SooHoo6, Amber Khanna7

    Congenital Heart Disease, Vol.19, No.5, pp. 457-472, 2024, DOI:10.32604/chd.2024.057151 - 31 December 2024

    Abstract Background: Post-operative atrial fibrillation (POAF) frequently occurs after cardiac surgery. Although adult congenital heart disease (ACHD) patients have higher rates of arrhythmia than the general population, there is scant literature on POAF in ACHD patients. Objectives: Identify key risk factors associated with post-operative atrial fibrillation and evaluate the short- and mid-term significance of developing POAF. Methods: A retrospective cohort study was conducted of ACHD patients from 2013–2021 at the University of Colorado Hospital and Children’s Hospital of Colorado. The institutional Society of Thoracic Surgeons (STS) surgical registry was used to identify patients ≥18-year-old with congenital heart… More >

  • Open Access

    REVIEW

    Sodium-Glucose Cotransporter 2 Inhibitors in Adult and Pediatric Congenital Heart Disease: Review of Emerging Data and Future Directions

    William H. Marshall V1,2,*, Lydia K. Wright2

    Congenital Heart Disease, Vol.19, No.4, pp. 419-433, 2024, DOI:10.32604/chd.2024.056608 - 31 October 2024

    Abstract Heart failure (HF) is common in patients with congenital heart disease (CHD) and there are limited medical therapies. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a proven medical therapy in patients with acquired HF, though data are limited in patients with CHD. The aim of this review is to summarize the current evidence for use of SGLT2i in patients with CHD and identify future directions for study. In available publications, SGLT2i in patients with CHD seem to be well tolerated, with similar side effect profile to patients with acquired HF. Improvement in functional capacity and natriuretic More >

  • Open Access

    REVIEW

    Right Axillary Thoracotomy Should Be the Standard of Care for Repair of Non-Complex Congenital Heart Defects in Infants and Children

    Sameh M. Said1,2,*, Yasin Essa1

    Congenital Heart Disease, Vol.19, No.4, pp. 407-417, 2024, DOI:10.32604/chd.2024.055636 - 31 October 2024

    Abstract Minimally invasive approaches for cardiac surgery in children have been lagging in comparison to the adult world. A wide range of the most common congenital heart defects in infants and children can be repaired successfully through a variety of non-sternotomy incisions. This has been shown to be associated with superior cosmetic results, shorter hospital stays, and rapid return to full activity compared to sternotomy. These approaches have been around for decades, but they have not been widely adopted for a variety of reasons. Right axillary thoracotomy is one of these approaches that we believe should More >

  • Open Access

    ARTICLE

    Standardized Management of Acute Pulmonary Hemorrhage after Percutaneous Pulmonary Vein Intervention

    Catalina Vargas-Acevedo1, Gareth J. Morgan1, Rhynn Soderstrom2, Richard Ing3, Nicholas Houska3, Jenny E. Zablah1,*

    Congenital Heart Disease, Vol.19, No.4, pp. 389-397, 2024, DOI:10.32604/chd.2024.055121 - 31 October 2024

    Abstract Introduction: Pulmonary hemorrhage (PHm) is a life-threatening complication that can occur after catheter-based interventions in patients with pulmonary vein stenosis (PVS). Inhaled racemic epinephrine (iRE) and tranexamic acid (iTXA) have been used in other conditions, but a standardized approach in PVS has not been described. We aimed to describe the current management of PHm after PVS catheter-based interventions. Methods: We present a retrospective review of episodes of PHm from July 2022 to February 2024. PHm was defined as frank blood suctioned from the endotracheal tube including blood-tinged secretions and >3% decrease in saturations and/or ventilatory… More >

Displaying 1-10 on page 1 of 266. Per Page